SHARE
COPY LINK

EBOLA

Denmark adds to its Ebola contributions

Denmark will contribute ten million kroner to help Ghana serve as a regional leader in the fight to contain the Ebola outbreak in west Africa.

Denmark adds to its Ebola contributions
Development Minister Mogens Jensen (right) announced the new contribution after meeting with Ghanaian President John Mahama (left) in Copenhagen. Photo: Keld Navntoft/Scanpix
The development and trade minister, Mogens Jensen, announced on Tuesday that Denmark will contribute an additional ten million kroner ($1.7 million) to Ghana to combat the Ebola virus. 
 
Jensen made the announcement after a meeting with Ghanaian President John Mahama at the Global Green Growth Forum in Copenhagen. 
 
“We are strengthening Ghana’s emergency health services so that we can contain the spread of Ebola more effectively, Jensen said in a press release. 
 
“The Ebola epidemic in west Africa is the largest outbreak in the history of the disease. The situation is developing day by day. We have to attack from all angles in order to get the epidemic under control as quickly as possible,” he added. 
 
With the new contribution, Denmark has donated a total of 74 million kroner toward the efforts to contain Ebola, including a total of 20 million kroner to Ghana alone. Ghana has thus had no recorded infections of Ebola but the country serves as a vital hub for regional efforts. 
 
Mahama is the head of the regional bloc Ecowas Commission, which is taking a leading role in the outbreak. ON Tuesday, he told the BBC that vital supplies have started to reach Guinea, Liberia and Sierra Leone, the three countries worst hit by the Ebola epidemic. 
 
“Vehicles, motorcycles and other means of transport are going in there. There's more protective clothing being provided. But there's no need for us to duplicate each other and have more treatment centres when we do not have volunteers and health workers to treat the people in the treatment centres,” Mahama said. 
 
The Ebola outbreak has killed more than 4,500 people, primarily in the three west African countries. 
 
Denmark has had a handful of recent Ebola scares, but all have proven to be false alarms. 

Member comments

Log in here to leave a comment.
Become a Member to leave a comment.

EBOLA

Spanish researchers develop five-strain vaccine against lethal Ebola virus

Spanish researchers are working on a vaccine against all five strains of the killer Ebola virus in what would be a world first, Madrid's October 12 Hospital said Wednesday (July 11).

Spanish researchers develop five-strain vaccine against lethal Ebola virus
Ebola protects itself with proteins that act as a shield, and only exposes its vulnerable zones for short periods of time. Photo: AFP

A prototype vaccine developed by pharmaceutical group Merck is already in use, but acts only against the most virulent, “Zaire” strain.

Despite not having market approval, Merck's rVSV-ZEBOV was administered to people in the Democratic Republic of Congo in May, with UN approval, in a bid to contain an outbreak of the same virus that killed more than 11,300 in three West African countries from 2013 to 2015, sparking international panic.

For several months, a team from the October 12 Hospital has been working with researchers at two other hospitals in the capital to examine and learn from blood samples taken from three people cured of Ebola in Spain.

Lead researcher Rafael Delgado told reporters the difficulty lay in the fact that the virus protects itself with proteins that act as a shield, and only exposes its vulnerable zones for short periods of time.

That makes it tough for the body's immune system to fight the virus.

The three Spanish patients had produced “very effective” viral antibodies, though in a “small quantity” and only against the Zaire strain they were contaminated with.

Delgado, head of microbiology at the hospital, said researchers are aiming to reproduce these antibodies on a larger scale, and in a way that would make them efficient against all five virus strains.

US medical giant Johnson & Johnson is separately developing an experimental vaccine against two Ebola strains.

Delgado said researchers hope to get results from mouse experiments within a year.

The Ebola epidemic caused alarm in Spain in 2014 when a nursing assistant, Teresa Romero, became the first person infected outside Africa.

She caught the disease while tending to a Spanish missionary repatriated from Sierra Leone, who died in Spain in September that year.